CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash Flows from Operating Activities:
Net loss	$ (4,654,808)	$ (1,648,072)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock-based compensation expense	744,612	741,145
(Recovery of) provision for doubtful accounts	(33,487)	95,546
Depreciation and amortization	1,915,470	2,115,678
Deferred taxes	561,451	360,882
Restructuring and other charges	105,113
Deferred rent	59,960	(163,899)
Changes in operating assets and liabilities:
Accounts receivable	565,073	695,408
Other receivables	320,457	53,501
Prepaid expenses and other current assets	(493,501)	(217,295)
Other assets	2,868	(81,259)
Accounts payable	76,692	45,008
Accrued expenses	485,575	(2,103,315)
Deferred revenue	1,241,539	1,299,920
Other current liabilities	(254,993)	(396,373)
Other liabilities	66,317	(39,585)
Net cash provided by operating activities	708,338	757,290
Cash Flows from Investing Activities:
Sale and maturity of marketable securities		2,005,484
Adjustment to purchase of Management Diagnostics Limited		50,494
Capital expenditures	(1,612,899)	(2,091,654)
Net cash used in investing activities	(1,612,899)	(35,676)
Cash Flows from Financing Activities:
Cash dividends paid on common stock	(11,929)	(1,780,956)
Cash dividends paid on preferred stock		(192,848)
Proceeds from the exercise of stock options		839
Restricted cash		139,750
Shares withheld on RSU vesting to pay for withholding taxes	(4,784)	(10,977)
Net cash used in financing activities	(16,713)	(1,844,192)
Effect of exchange rate changes on cash and cash equivalents	(358,920)	4,992
Net decrease in cash and cash equivalents	(1,280,194)	(1,117,586)
Cash and cash equivalents, beginning of period	28,445,416	32,459,009
Cash and cash equivalents, end of period	$ 27,165,222	$ 31,341,423